Nurix Therapeutics, Inc. (NRIX)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

2

(1)

7

0

2

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
26-Aug-24 5:41 PM View:	26-Aug-24 Sale (Planned) ($504.37K)	van Houte Hans Chief Financial Officer		Nurix Therapeutics, Inc. - NRIX	(64%) 86.38K to 31.0K	0	0	--	--	Show Txns Hide Txns

30-Jul-24 7:06 PM View:	30-Jul-24 Option Sale ($70.44K)	Hansen Gwenn Chief Scientific Officer		Nurix Therapeutics, Inc. - NRIX	35% 33.53K to 45.15K	0	0	--	--	Show Txns Hide Txns

18-Jul-24 4:06 PM View:	17-Jul-24 Gift 0	Kunkel Lori Anne Director		Nurix Therapeutics, Inc. - NRIX	(100%) 54.03K to 0	0	0	--	--	Show Txns Hide Txns

15-Oct-24 9:16 AM View:	14-Oct-24 Planned Option Sale ($82.25K)	Ring Christine Chief Legal Officer		Nurix Therapeutics, Inc. - NRIX	61% 15.26K to 24.59K	0	0	--	--	Show Txns Hide Txns